Sort
16,300 grants matching “fatty liver disease”
Clinical Research Network in Non-Alcoholic Steatohepati*
$904,151Johns Hopkins University · U01 · FY2002 · DK
Modeling diabetes using an integrated plate system
$904,048James M Wells · Cincinnati Childrens Hosp Med Ctr · UG3 · FY2018 · DK
TOPMed Omics of Type 2 Diabetes and Quantitative Traits
$902,027James B Meigs · Massachusetts General Hospital · UM1 · FY2021 · DK
Novel Small Molecules For Acute Liver Failure
$900,132Prakash Narayan · Angion Biomedica Corporation · R44 · FY2007 · AA
Framingham Heart Study/Fox
$899,689Caroline Fox · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
$899,417M. Celeste Simon · University Of Pennsylvania · R35 · FY2017 · CA
CVD in American Indians Study and Data Management Center and OK Field Center
$897,599Julie A Stoner · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2016 · HL
CVD in American Indians Study and Data Management Center and OK Field Center
$897,599Julie A Stoner · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2017 · HL
Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes
$897,025Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
$896,990Farhad Parhami · Max Biopharma, Inc. · R44 · FY2023 · DK
Novel therapeutics for fatty liver disease and type-II diabetes
$895,454Sarah A Compton · Southeast Techinventures, Inc. · R44 · FY2015 · DK
Statistical methods and designs for correlated outcome and covariate errors in studies of HIV/AIDS
$893,452Bryan Earl Shepherd · Vanderbilt University Medical Center · R37 · FY2023 · AI
Mediators of fatty liver disease during HIV/SIV and cART treatment
$893,138Donald L Sodora · Seattle Children'S Hospital · R01 · FY2019 · AI
The Molecular Profile of Prostate Tumors in African-American Men
$891,624Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Molecular signatures for liver cancer diagnosis and treatment stratification
$891,493Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
FETAL BODY COMPOSITION AND VOLUMES STUDY
$891,211Wesley Lee · Baylor College Of Medicine · N01 · FY2017 · HD
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
$889,701Farhad Parhami · Max Biopharma, Inc. · R44 · FY2024 · DK
Cellular mechanisms of neuronal dysfunction
$889,518Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2017 · DA
Endothelial cell targeting of factor VIII for hemophilia A
$888,836Denise E Sabatino · Children'S Hosp Of Philadelphia · R01 · FY2025 · HL
Immunologic Mechanisms of Alcoholic Liver Disease
$888,227Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA
Early Life Social, Environmental, and Nutritional Determinants of Disease (ELSEND)
$888,180Michael I Goran · Children'S Hospital Of Los Angeles · P50 · FY2022 · MD
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$884,823Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
CVD in American Indians Study and Data Management Center and OK Field Center
$884,135Elisa Lee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2015 · HL
Early Life Social, Environmental, and Nutritional Determinants of Disease (ELSEND)
$883,678Michael I Goran · Children'S Hospital Of Los Angeles · P50 · FY2023 · MD
Molecular Biology of the Metastatic Phenotype
$883,640Patricia Schriver Steeg · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA